nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.228	1	CpDpCtD
Pergolide—Ergonovine—Bromocriptine—type 2 diabetes mellitus	0.126	0.5	CrCrCtD
Pergolide—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.126	0.5	CrCrCtD
Pergolide—ADRA2A—type 2 diabetes mellitus	0.0673	0.42	CbGaD
Pergolide—HTR2C—type 2 diabetes mellitus	0.0619	0.387	CbGaD
Pergolide—CYP3A4—type 2 diabetes mellitus	0.0309	0.193	CbGaD
Pergolide—DRD5—Bromocriptine—type 2 diabetes mellitus	0.0229	0.0991	CbGbCtD
Pergolide—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0163	0.0707	CbGbCtD
Pergolide—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0134	0.0582	CbGbCtD
Pergolide—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0131	0.0569	CbGbCtD
Pergolide—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0129	0.0558	CbGbCtD
Pergolide—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0129	0.0558	CbGbCtD
Pergolide—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0121	0.0525	CbGbCtD
Pergolide—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0117	0.0506	CbGbCtD
Pergolide—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0117	0.0506	CbGbCtD
Pergolide—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0111	0.048	CbGbCtD
Pergolide—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.00936	0.0406	CbGbCtD
Pergolide—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.00855	0.0371	CbGbCtD
Pergolide—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.00806	0.0349	CbGbCtD
Pergolide—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.00771	0.0334	CbGbCtD
Pergolide—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.00771	0.0334	CbGbCtD
Pergolide—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.00739	0.032	CbGbCtD
Pergolide—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0071	0.0308	CbGbCtD
Pergolide—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00373	0.0162	CbGbCtD
Pergolide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00368	0.016	CbGbCtD
Pergolide—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00344	0.0149	CbGbCtD
Pergolide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00328	0.0142	CbGbCtD
Pergolide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.003	0.013	CbGbCtD
Pergolide—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00283	0.0123	CbGbCtD
Pergolide—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00271	0.0117	CbGbCtD
Pergolide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00262	0.0114	CbGbCtD
Pergolide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00237	0.0103	CbGbCtD
Pergolide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0018	0.00779	CbGbCtD
Pergolide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00172	0.00747	CbGbCtD
Pergolide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00172	0.00747	CbGbCtD
Pergolide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00163	0.00706	CbGbCtD
Pergolide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00121	0.00526	CbGbCtD
Pergolide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00111	0.00481	CbGbCtD
Pergolide—HTR2A—arteriole—type 2 diabetes mellitus	0.000999	0.104	CbGeAlD
Pergolide—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.000637	0.0665	CbGeAlD
Pergolide—DRD1—nerve—type 2 diabetes mellitus	0.000618	0.0646	CbGeAlD
Pergolide—HTR1B—artery—type 2 diabetes mellitus	0.000505	0.0527	CbGeAlD
Pergolide—HTR1D—artery—type 2 diabetes mellitus	0.000489	0.0511	CbGeAlD
Pergolide—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000428	0.0447	CbGeAlD
Pergolide—HTR2A—hindlimb—type 2 diabetes mellitus	0.000396	0.0414	CbGeAlD
Pergolide—DRD2—nerve—type 2 diabetes mellitus	0.000365	0.0381	CbGeAlD
Pergolide—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000363	0.038	CbGeAlD
Pergolide—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000309	0.0323	CbGeAlD
Pergolide—HTR2A—artery—type 2 diabetes mellitus	0.000243	0.0254	CbGeAlD
Pergolide—HTR2A—nerve—type 2 diabetes mellitus	0.000241	0.0252	CbGeAlD
Pergolide—Ergonovine—HTR2C—type 2 diabetes mellitus	0.000239	0.152	CrCbGaD
Pergolide—ADRA1B—kidney—type 2 diabetes mellitus	0.000227	0.0237	CbGeAlD
Pergolide—Cabergoline—ADRA2A—type 2 diabetes mellitus	0.000227	0.144	CrCbGaD
Pergolide—Cabergoline—HTR2C—type 2 diabetes mellitus	0.000209	0.133	CrCbGaD
Pergolide—Methylergometrine—HTR2C—type 2 diabetes mellitus	0.000209	0.133	CrCbGaD
Pergolide—HTR2A—endothelium—type 2 diabetes mellitus	0.000205	0.0214	CbGeAlD
Pergolide—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000175	0.0183	CbGeAlD
Pergolide—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000174	0.0182	CbGeAlD
Pergolide—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.00017	0.0177	CbGeAlD
Pergolide—HTR1D—kidney—type 2 diabetes mellitus	0.000166	0.0174	CbGeAlD
Pergolide—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000158	0.0165	CbGeAlD
Pergolide—Lisuride—ADRA2A—type 2 diabetes mellitus	0.000152	0.0967	CrCbGaD
Pergolide—DRD2—retina—type 2 diabetes mellitus	0.000151	0.0158	CbGeAlD
Pergolide—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000151	0.0157	CbGeAlD
Pergolide—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000142	0.0148	CbGeAlD
Pergolide—Lisuride—HTR2C—type 2 diabetes mellitus	0.00014	0.089	CrCbGaD
Pergolide—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000139	0.0146	CbGeAlD
Pergolide—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000138	0.0145	CbGeAlD
Pergolide—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000137	0.0143	CbGeAlD
Pergolide—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.00013	0.0136	CbGeAlD
Pergolide—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000126	0.0132	CbGeAlD
Pergolide—ADRA2C—kidney—type 2 diabetes mellitus	0.000122	0.0127	CbGeAlD
Pergolide—ADRA2C—pancreas—type 2 diabetes mellitus	0.000121	0.0126	CbGeAlD
Pergolide—Ergonovine—CYP3A4—type 2 diabetes mellitus	0.000119	0.0758	CrCbGaD
Pergolide—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000118	0.0124	CbGeAlD
Pergolide—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000115	0.012	CbGeAlD
Pergolide—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.00011	0.0115	CbGeAlD
Pergolide—Cabergoline—CYP3A4—type 2 diabetes mellitus	0.000104	0.0663	CrCbGaD
Pergolide—Methylergometrine—CYP3A4—type 2 diabetes mellitus	0.000104	0.0663	CrCbGaD
Pergolide—HTR2A—retina—type 2 diabetes mellitus	9.97e-05	0.0104	CbGeAlD
Pergolide—ADRA2A—pancreas—type 2 diabetes mellitus	9.64e-05	0.0101	CbGeAlD
Pergolide—ADRA2A—cortex of kidney—type 2 diabetes mellitus	9.45e-05	0.00988	CbGeAlD
Pergolide—ADRA2A—adipose tissue—type 2 diabetes mellitus	8.75e-05	0.00914	CbGeAlD
Pergolide—HTR2A—cardiovascular system—type 2 diabetes mellitus	8.44e-05	0.00881	CbGeAlD
Pergolide—HTR2A—kidney—type 2 diabetes mellitus	8.25e-05	0.00862	CbGeAlD
Pergolide—ADRA1A—liver—type 2 diabetes mellitus	8.07e-05	0.00843	CbGeAlD
Pergolide—ADRA2C—liver—type 2 diabetes mellitus	7.69e-05	0.00803	CbGeAlD
Pergolide—CYP3A4—kidney—type 2 diabetes mellitus	7.64e-05	0.00798	CbGeAlD
Pergolide—CYP2D6—kidney—type 2 diabetes mellitus	7.52e-05	0.00786	CbGeAlD
Pergolide—Lisuride—CYP3A4—type 2 diabetes mellitus	7e-05	0.0445	CrCbGaD
Pergolide—HTR2A—liver—type 2 diabetes mellitus	5.22e-05	0.00545	CbGeAlD
Pergolide—CYP3A4—liver—type 2 diabetes mellitus	4.83e-05	0.00505	CbGeAlD
Pergolide—CYP2D6—liver—type 2 diabetes mellitus	4.75e-05	0.00497	CbGeAlD
Pergolide—Vertigo—Irbesartan—type 2 diabetes mellitus	3.09e-05	0.00043	CcSEcCtD
Pergolide—Headache—Pioglitazone—type 2 diabetes mellitus	3.09e-05	0.00043	CcSEcCtD
Pergolide—Syncope—Irbesartan—type 2 diabetes mellitus	3.08e-05	0.00043	CcSEcCtD
Pergolide—Leukopenia—Irbesartan—type 2 diabetes mellitus	3.08e-05	0.000429	CcSEcCtD
Pergolide—Visual impairment—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000428	CcSEcCtD
Pergolide—Discomfort—Metformin—type 2 diabetes mellitus	3.07e-05	0.000427	CcSEcCtD
Pergolide—Nausea—Glipizide—type 2 diabetes mellitus	3.06e-05	0.000426	CcSEcCtD
Pergolide—Vomiting—Glimepiride—type 2 diabetes mellitus	3.05e-05	0.000425	CcSEcCtD
Pergolide—Hypotension—Valsartan—type 2 diabetes mellitus	3.05e-05	0.000425	CcSEcCtD
Pergolide—Vomiting—Sitagliptin—type 2 diabetes mellitus	3.04e-05	0.000424	CcSEcCtD
Pergolide—Constipation—Gliclazide—type 2 diabetes mellitus	3.04e-05	0.000424	CcSEcCtD
Pergolide—Pain—Gliclazide—type 2 diabetes mellitus	3.04e-05	0.000424	CcSEcCtD
Pergolide—Tremor—Losartan—type 2 diabetes mellitus	3.03e-05	0.000422	CcSEcCtD
Pergolide—Rash—Glimepiride—type 2 diabetes mellitus	3.03e-05	0.000422	CcSEcCtD
Pergolide—Dermatitis—Glimepiride—type 2 diabetes mellitus	3.02e-05	0.000421	CcSEcCtD
Pergolide—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	3.02e-05	0.000421	CcSEcCtD
Pergolide—Rash—Sitagliptin—type 2 diabetes mellitus	3.02e-05	0.00042	CcSEcCtD
Pergolide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	3.01e-05	0.00042	CcSEcCtD
Pergolide—Headache—Glimepiride—type 2 diabetes mellitus	3.01e-05	0.000419	CcSEcCtD
Pergolide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	3e-05	0.000418	CcSEcCtD
Pergolide—Cough—Irbesartan—type 2 diabetes mellitus	3e-05	0.000418	CcSEcCtD
Pergolide—Headache—Sitagliptin—type 2 diabetes mellitus	3e-05	0.000418	CcSEcCtD
Pergolide—Anaemia—Losartan—type 2 diabetes mellitus	2.99e-05	0.000417	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	2.98e-05	0.000415	CcSEcCtD
Pergolide—Agitation—Losartan—type 2 diabetes mellitus	2.97e-05	0.000414	CcSEcCtD
Pergolide—Oedema—Metformin—type 2 diabetes mellitus	2.97e-05	0.000414	CcSEcCtD
Pergolide—Tinnitus—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000414	CcSEcCtD
Pergolide—Hypertension—Irbesartan—type 2 diabetes mellitus	2.97e-05	0.000414	CcSEcCtD
Pergolide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	2.96e-05	0.000413	CcSEcCtD
Pergolide—Infection—Metformin—type 2 diabetes mellitus	2.96e-05	0.000412	CcSEcCtD
Pergolide—Insomnia—Valsartan—type 2 diabetes mellitus	2.95e-05	0.000412	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	2.94e-05	0.00041	CcSEcCtD
Pergolide—Paraesthesia—Valsartan—type 2 diabetes mellitus	2.93e-05	0.000409	CcSEcCtD
Pergolide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	2.93e-05	0.000408	CcSEcCtD
Pergolide—Myalgia—Irbesartan—type 2 diabetes mellitus	2.93e-05	0.000408	CcSEcCtD
Pergolide—Chest pain—Irbesartan—type 2 diabetes mellitus	2.93e-05	0.000408	CcSEcCtD
Pergolide—Arthralgia—Irbesartan—type 2 diabetes mellitus	2.93e-05	0.000408	CcSEcCtD
Pergolide—Shock—Metformin—type 2 diabetes mellitus	2.93e-05	0.000408	CcSEcCtD
Pergolide—Insomnia—Orlistat—type 2 diabetes mellitus	2.92e-05	0.000407	CcSEcCtD
Pergolide—Malaise—Losartan—type 2 diabetes mellitus	2.92e-05	0.000407	CcSEcCtD
Pergolide—Anxiety—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000407	CcSEcCtD
Pergolide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	2.91e-05	0.000406	CcSEcCtD
Pergolide—Dyspnoea—Valsartan—type 2 diabetes mellitus	2.91e-05	0.000406	CcSEcCtD
Pergolide—Vertigo—Losartan—type 2 diabetes mellitus	2.91e-05	0.000405	CcSEcCtD
Pergolide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	2.91e-05	0.000405	CcSEcCtD
Pergolide—Somnolence—Valsartan—type 2 diabetes mellitus	2.9e-05	0.000405	CcSEcCtD
Pergolide—Syncope—Losartan—type 2 diabetes mellitus	2.9e-05	0.000404	CcSEcCtD
Pergolide—Paraesthesia—Orlistat—type 2 diabetes mellitus	2.9e-05	0.000404	CcSEcCtD
Pergolide—Leukopenia—Losartan—type 2 diabetes mellitus	2.9e-05	0.000404	CcSEcCtD
Pergolide—Discomfort—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000403	CcSEcCtD
Pergolide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	2.88e-05	0.000401	CcSEcCtD
Pergolide—Dyspepsia—Valsartan—type 2 diabetes mellitus	2.88e-05	0.000401	CcSEcCtD
Pergolide—Dizziness—Bromocriptine—type 2 diabetes mellitus	2.86e-05	0.000399	CcSEcCtD
Pergolide—Dry mouth—Irbesartan—type 2 diabetes mellitus	2.86e-05	0.000399	CcSEcCtD
Pergolide—Palpitations—Losartan—type 2 diabetes mellitus	2.86e-05	0.000398	CcSEcCtD
Pergolide—Nausea—Glimepiride—type 2 diabetes mellitus	2.85e-05	0.000397	CcSEcCtD
Pergolide—Arrhythmia—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000397	CcSEcCtD
Pergolide—Loss of consciousness—Losartan—type 2 diabetes mellitus	2.84e-05	0.000396	CcSEcCtD
Pergolide—Nausea—Sitagliptin—type 2 diabetes mellitus	2.84e-05	0.000396	CcSEcCtD
Pergolide—Dyspepsia—Orlistat—type 2 diabetes mellitus	2.84e-05	0.000396	CcSEcCtD
Pergolide—Asthenia—Glyburide—type 2 diabetes mellitus	2.84e-05	0.000396	CcSEcCtD
Pergolide—Decreased appetite—Valsartan—type 2 diabetes mellitus	2.84e-05	0.000396	CcSEcCtD
Pergolide—Anorexia—Metformin—type 2 diabetes mellitus	2.84e-05	0.000395	CcSEcCtD
Pergolide—Cough—Losartan—type 2 diabetes mellitus	2.82e-05	0.000393	CcSEcCtD
Pergolide—Alopecia—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000392	CcSEcCtD
Pergolide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	2.81e-05	0.000392	CcSEcCtD
Pergolide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	2.81e-05	0.000392	CcSEcCtD
Pergolide—Oedema—Irbesartan—type 2 diabetes mellitus	2.81e-05	0.000391	CcSEcCtD
Pergolide—Decreased appetite—Orlistat—type 2 diabetes mellitus	2.81e-05	0.000391	CcSEcCtD
Pergolide—Pruritus—Glyburide—type 2 diabetes mellitus	2.8e-05	0.00039	CcSEcCtD
Pergolide—Constipation—Valsartan—type 2 diabetes mellitus	2.79e-05	0.000389	CcSEcCtD
Pergolide—Infection—Irbesartan—type 2 diabetes mellitus	2.79e-05	0.000388	CcSEcCtD
Pergolide—Hypotension—Metformin—type 2 diabetes mellitus	2.78e-05	0.000387	CcSEcCtD
Pergolide—Shock—Irbesartan—type 2 diabetes mellitus	2.76e-05	0.000385	CcSEcCtD
Pergolide—Pain—Orlistat—type 2 diabetes mellitus	2.76e-05	0.000384	CcSEcCtD
Pergolide—Arthralgia—Losartan—type 2 diabetes mellitus	2.76e-05	0.000384	CcSEcCtD
Pergolide—Chest pain—Losartan—type 2 diabetes mellitus	2.76e-05	0.000384	CcSEcCtD
Pergolide—Myalgia—Losartan—type 2 diabetes mellitus	2.76e-05	0.000384	CcSEcCtD
Pergolide—Vomiting—Bromocriptine—type 2 diabetes mellitus	2.75e-05	0.000384	CcSEcCtD
Pergolide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	2.75e-05	0.000383	CcSEcCtD
Pergolide—Anxiety—Losartan—type 2 diabetes mellitus	2.75e-05	0.000383	CcSEcCtD
Pergolide—Tachycardia—Irbesartan—type 2 diabetes mellitus	2.74e-05	0.000382	CcSEcCtD
Pergolide—Rash—Bromocriptine—type 2 diabetes mellitus	2.73e-05	0.00038	CcSEcCtD
Pergolide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	2.73e-05	0.00038	CcSEcCtD
Pergolide—Tension—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000379	CcSEcCtD
Pergolide—Discomfort—Losartan—type 2 diabetes mellitus	2.72e-05	0.000379	CcSEcCtD
Pergolide—Dysgeusia—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000379	CcSEcCtD
Pergolide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	2.71e-05	0.000378	CcSEcCtD
Pergolide—Headache—Bromocriptine—type 2 diabetes mellitus	2.71e-05	0.000378	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	2.71e-05	0.000378	CcSEcCtD
Pergolide—Diarrhoea—Glyburide—type 2 diabetes mellitus	2.71e-05	0.000377	CcSEcCtD
Pergolide—Nervousness—Ramipril—type 2 diabetes mellitus	2.7e-05	0.000376	CcSEcCtD
Pergolide—Dry mouth—Losartan—type 2 diabetes mellitus	2.7e-05	0.000375	CcSEcCtD
Pergolide—Anorexia—Irbesartan—type 2 diabetes mellitus	2.68e-05	0.000373	CcSEcCtD
Pergolide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	2.67e-05	0.000372	CcSEcCtD
Pergolide—Paraesthesia—Metformin—type 2 diabetes mellitus	2.67e-05	0.000372	CcSEcCtD
Pergolide—Confusional state—Losartan—type 2 diabetes mellitus	2.66e-05	0.000371	CcSEcCtD
Pergolide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	2.66e-05	0.000371	CcSEcCtD
Pergolide—Dyspnoea—Metformin—type 2 diabetes mellitus	2.65e-05	0.000369	CcSEcCtD
Pergolide—Somnolence—Metformin—type 2 diabetes mellitus	2.64e-05	0.000368	CcSEcCtD
Pergolide—Oedema—Losartan—type 2 diabetes mellitus	2.64e-05	0.000368	CcSEcCtD
Pergolide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	2.64e-05	0.000368	CcSEcCtD
Pergolide—Infection—Losartan—type 2 diabetes mellitus	2.62e-05	0.000366	CcSEcCtD
Pergolide—Hypotension—Irbesartan—type 2 diabetes mellitus	2.62e-05	0.000365	CcSEcCtD
Pergolide—Dyspepsia—Metformin—type 2 diabetes mellitus	2.62e-05	0.000365	CcSEcCtD
Pergolide—Tremor—Ramipril—type 2 diabetes mellitus	2.6e-05	0.000362	CcSEcCtD
Pergolide—Shock—Losartan—type 2 diabetes mellitus	2.6e-05	0.000362	CcSEcCtD
Pergolide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	2.59e-05	0.00036	CcSEcCtD
Pergolide—Decreased appetite—Metformin—type 2 diabetes mellitus	2.59e-05	0.00036	CcSEcCtD
Pergolide—Abdominal pain—Valsartan—type 2 diabetes mellitus	2.58e-05	0.00036	CcSEcCtD
Pergolide—Tachycardia—Losartan—type 2 diabetes mellitus	2.58e-05	0.000359	CcSEcCtD
Pergolide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000359	CcSEcCtD
Pergolide—Nausea—Bromocriptine—type 2 diabetes mellitus	2.57e-05	0.000358	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	2.56e-05	0.000356	CcSEcCtD
Pergolide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	2.55e-05	0.000356	CcSEcCtD
Pergolide—Abdominal pain—Orlistat—type 2 diabetes mellitus	2.55e-05	0.000355	CcSEcCtD
Pergolide—Body temperature increased—Orlistat—type 2 diabetes mellitus	2.55e-05	0.000355	CcSEcCtD
Pergolide—Asthenia—Gliclazide—type 2 diabetes mellitus	2.55e-05	0.000355	CcSEcCtD
Pergolide—Agitation—Ramipril—type 2 diabetes mellitus	2.55e-05	0.000355	CcSEcCtD
Pergolide—Constipation—Metformin—type 2 diabetes mellitus	2.54e-05	0.000354	CcSEcCtD
Pergolide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	2.52e-05	0.000351	CcSEcCtD
Pergolide—Anorexia—Losartan—type 2 diabetes mellitus	2.52e-05	0.000351	CcSEcCtD
Pergolide—Vomiting—Glyburide—type 2 diabetes mellitus	2.52e-05	0.000351	CcSEcCtD
Pergolide—Pruritus—Gliclazide—type 2 diabetes mellitus	2.52e-05	0.00035	CcSEcCtD
Pergolide—Malaise—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000349	CcSEcCtD
Pergolide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	2.5e-05	0.000349	CcSEcCtD
Pergolide—Rash—Glyburide—type 2 diabetes mellitus	2.5e-05	0.000348	CcSEcCtD
Pergolide—Somnolence—Irbesartan—type 2 diabetes mellitus	2.5e-05	0.000348	CcSEcCtD
Pergolide—Dermatitis—Glyburide—type 2 diabetes mellitus	2.49e-05	0.000347	CcSEcCtD
Pergolide—Vertigo—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000347	CcSEcCtD
Pergolide—Syncope—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000347	CcSEcCtD
Pergolide—Leukopenia—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000346	CcSEcCtD
Pergolide—Headache—Glyburide—type 2 diabetes mellitus	2.48e-05	0.000346	CcSEcCtD
Pergolide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	2.47e-05	0.000344	CcSEcCtD
Pergolide—Hypotension—Losartan—type 2 diabetes mellitus	2.47e-05	0.000344	CcSEcCtD
Pergolide—Palpitations—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000342	CcSEcCtD
Pergolide—Feeling abnormal—Metformin—type 2 diabetes mellitus	2.45e-05	0.000341	CcSEcCtD
Pergolide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	2.44e-05	0.00034	CcSEcCtD
Pergolide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	2.44e-05	0.00034	CcSEcCtD
Pergolide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.43e-05	0.000339	CcSEcCtD
Pergolide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	2.43e-05	0.000339	CcSEcCtD
Pergolide—Cough—Ramipril—type 2 diabetes mellitus	2.42e-05	0.000337	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.41e-05	0.000335	CcSEcCtD
Pergolide—Convulsion—Ramipril—type 2 diabetes mellitus	2.4e-05	0.000335	CcSEcCtD
Pergolide—Constipation—Irbesartan—type 2 diabetes mellitus	2.4e-05	0.000334	CcSEcCtD
Pergolide—Pain—Irbesartan—type 2 diabetes mellitus	2.4e-05	0.000334	CcSEcCtD
Pergolide—Insomnia—Losartan—type 2 diabetes mellitus	2.39e-05	0.000333	CcSEcCtD
Pergolide—Paraesthesia—Losartan—type 2 diabetes mellitus	2.37e-05	0.00033	CcSEcCtD
Pergolide—Chest pain—Ramipril—type 2 diabetes mellitus	2.36e-05	0.000329	CcSEcCtD
Pergolide—Arthralgia—Ramipril—type 2 diabetes mellitus	2.36e-05	0.000329	CcSEcCtD
Pergolide—Myalgia—Ramipril—type 2 diabetes mellitus	2.36e-05	0.000329	CcSEcCtD
Pergolide—Dyspnoea—Losartan—type 2 diabetes mellitus	2.36e-05	0.000328	CcSEcCtD
Pergolide—Anxiety—Ramipril—type 2 diabetes mellitus	2.35e-05	0.000328	CcSEcCtD
Pergolide—Nausea—Glyburide—type 2 diabetes mellitus	2.35e-05	0.000328	CcSEcCtD
Pergolide—Abdominal pain—Metformin—type 2 diabetes mellitus	2.35e-05	0.000328	CcSEcCtD
Pergolide—Dizziness—Gliclazide—type 2 diabetes mellitus	2.35e-05	0.000328	CcSEcCtD
Pergolide—Somnolence—Losartan—type 2 diabetes mellitus	2.35e-05	0.000327	CcSEcCtD
Pergolide—Asthenia—Valsartan—type 2 diabetes mellitus	2.34e-05	0.000326	CcSEcCtD
Pergolide—Discomfort—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000325	CcSEcCtD
Pergolide—Dyspepsia—Losartan—type 2 diabetes mellitus	2.33e-05	0.000324	CcSEcCtD
Pergolide—Asthenia—Orlistat—type 2 diabetes mellitus	2.32e-05	0.000323	CcSEcCtD
Pergolide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	2.31e-05	0.000322	CcSEcCtD
Pergolide—Pruritus—Valsartan—type 2 diabetes mellitus	2.31e-05	0.000322	CcSEcCtD
Pergolide—Dry mouth—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000322	CcSEcCtD
Pergolide—Decreased appetite—Losartan—type 2 diabetes mellitus	2.3e-05	0.00032	CcSEcCtD
Pergolide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.3e-05	0.00032	CcSEcCtD
Pergolide—Confusional state—Ramipril—type 2 diabetes mellitus	2.28e-05	0.000318	CcSEcCtD
Pergolide—Pruritus—Orlistat—type 2 diabetes mellitus	2.28e-05	0.000318	CcSEcCtD
Pergolide—Oedema—Ramipril—type 2 diabetes mellitus	2.27e-05	0.000316	CcSEcCtD
Pergolide—Vomiting—Gliclazide—type 2 diabetes mellitus	2.26e-05	0.000315	CcSEcCtD
Pergolide—Pain—Losartan—type 2 diabetes mellitus	2.26e-05	0.000315	CcSEcCtD
Pergolide—Constipation—Losartan—type 2 diabetes mellitus	2.26e-05	0.000315	CcSEcCtD
Pergolide—Rash—Gliclazide—type 2 diabetes mellitus	2.24e-05	0.000312	CcSEcCtD
Pergolide—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.24e-05	0.000312	CcSEcCtD
Pergolide—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.23e-05	0.000311	CcSEcCtD
Pergolide—Shock—Ramipril—type 2 diabetes mellitus	2.23e-05	0.00031	CcSEcCtD
Pergolide—Headache—Gliclazide—type 2 diabetes mellitus	2.23e-05	0.00031	CcSEcCtD
Pergolide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.22e-05	0.000309	CcSEcCtD
Pergolide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	2.22e-05	0.000309	CcSEcCtD
Pergolide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.22e-05	0.000309	CcSEcCtD
Pergolide—Tachycardia—Ramipril—type 2 diabetes mellitus	2.21e-05	0.000308	CcSEcCtD
Pergolide—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.21e-05	0.000308	CcSEcCtD
Pergolide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	2.19e-05	0.000305	CcSEcCtD
Pergolide—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.18e-05	0.000303	CcSEcCtD
Pergolide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.16e-05	0.000301	CcSEcCtD
Pergolide—Dizziness—Valsartan—type 2 diabetes mellitus	2.16e-05	0.000301	CcSEcCtD
Pergolide—Anorexia—Ramipril—type 2 diabetes mellitus	2.16e-05	0.000301	CcSEcCtD
Pergolide—Dizziness—Orlistat—type 2 diabetes mellitus	2.13e-05	0.000297	CcSEcCtD
Pergolide—Asthenia—Metformin—type 2 diabetes mellitus	2.13e-05	0.000297	CcSEcCtD
Pergolide—Hypotension—Ramipril—type 2 diabetes mellitus	2.12e-05	0.000295	CcSEcCtD
Pergolide—Nausea—Gliclazide—type 2 diabetes mellitus	2.11e-05	0.000294	CcSEcCtD
Pergolide—Pruritus—Metformin—type 2 diabetes mellitus	2.1e-05	0.000293	CcSEcCtD
Pergolide—Abdominal pain—Losartan—type 2 diabetes mellitus	2.09e-05	0.000291	CcSEcCtD
Pergolide—Body temperature increased—Losartan—type 2 diabetes mellitus	2.09e-05	0.000291	CcSEcCtD
Pergolide—Vomiting—Valsartan—type 2 diabetes mellitus	2.08e-05	0.000289	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.06e-05	0.000287	CcSEcCtD
Pergolide—Rash—Valsartan—type 2 diabetes mellitus	2.06e-05	0.000287	CcSEcCtD
Pergolide—Dermatitis—Valsartan—type 2 diabetes mellitus	2.06e-05	0.000287	CcSEcCtD
Pergolide—Vomiting—Orlistat—type 2 diabetes mellitus	2.05e-05	0.000286	CcSEcCtD
Pergolide—Insomnia—Ramipril—type 2 diabetes mellitus	2.05e-05	0.000285	CcSEcCtD
Pergolide—Headache—Valsartan—type 2 diabetes mellitus	2.05e-05	0.000285	CcSEcCtD
Pergolide—Diarrhoea—Metformin—type 2 diabetes mellitus	2.04e-05	0.000284	CcSEcCtD
Pergolide—Rash—Orlistat—type 2 diabetes mellitus	2.04e-05	0.000283	CcSEcCtD
Pergolide—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.03e-05	0.000283	CcSEcCtD
Pergolide—Dermatitis—Orlistat—type 2 diabetes mellitus	2.03e-05	0.000283	CcSEcCtD
Pergolide—Headache—Orlistat—type 2 diabetes mellitus	2.02e-05	0.000282	CcSEcCtD
Pergolide—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.02e-05	0.000281	CcSEcCtD
Pergolide—Asthenia—Irbesartan—type 2 diabetes mellitus	2.01e-05	0.000281	CcSEcCtD
Pergolide—Somnolence—Ramipril—type 2 diabetes mellitus	2.01e-05	0.000281	CcSEcCtD
Pergolide—Dyspepsia—Ramipril—type 2 diabetes mellitus	1.99e-05	0.000278	CcSEcCtD
Pergolide—Pruritus—Irbesartan—type 2 diabetes mellitus	1.99e-05	0.000277	CcSEcCtD
Pergolide—Decreased appetite—Ramipril—type 2 diabetes mellitus	1.97e-05	0.000274	CcSEcCtD
Pergolide—Dizziness—Metformin—type 2 diabetes mellitus	1.97e-05	0.000274	CcSEcCtD
Pergolide—Nausea—Valsartan—type 2 diabetes mellitus	1.94e-05	0.00027	CcSEcCtD
Pergolide—Constipation—Ramipril—type 2 diabetes mellitus	1.94e-05	0.00027	CcSEcCtD
Pergolide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.92e-05	0.000268	CcSEcCtD
Pergolide—Nausea—Orlistat—type 2 diabetes mellitus	1.92e-05	0.000267	CcSEcCtD
Pergolide—Asthenia—Losartan—type 2 diabetes mellitus	1.9e-05	0.000264	CcSEcCtD
Pergolide—Vomiting—Metformin—type 2 diabetes mellitus	1.89e-05	0.000263	CcSEcCtD
Pergolide—Rash—Metformin—type 2 diabetes mellitus	1.88e-05	0.000261	CcSEcCtD
Pergolide—Dermatitis—Metformin—type 2 diabetes mellitus	1.87e-05	0.000261	CcSEcCtD
Pergolide—Pruritus—Losartan—type 2 diabetes mellitus	1.87e-05	0.00026	CcSEcCtD
Pergolide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.87e-05	0.00026	CcSEcCtD
Pergolide—Headache—Metformin—type 2 diabetes mellitus	1.86e-05	0.00026	CcSEcCtD
Pergolide—Dizziness—Irbesartan—type 2 diabetes mellitus	1.86e-05	0.000259	CcSEcCtD
Pergolide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.85e-05	0.000258	CcSEcCtD
Pergolide—Diarrhoea—Losartan—type 2 diabetes mellitus	1.81e-05	0.000252	CcSEcCtD
Pergolide—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.79e-05	0.000249	CcSEcCtD
Pergolide—Body temperature increased—Ramipril—type 2 diabetes mellitus	1.79e-05	0.000249	CcSEcCtD
Pergolide—Vomiting—Irbesartan—type 2 diabetes mellitus	1.78e-05	0.000249	CcSEcCtD
Pergolide—Rash—Irbesartan—type 2 diabetes mellitus	1.77e-05	0.000247	CcSEcCtD
Pergolide—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.77e-05	0.000246	CcSEcCtD
Pergolide—Nausea—Metformin—type 2 diabetes mellitus	1.77e-05	0.000246	CcSEcCtD
Pergolide—Headache—Irbesartan—type 2 diabetes mellitus	1.76e-05	0.000245	CcSEcCtD
Pergolide—Dizziness—Losartan—type 2 diabetes mellitus	1.75e-05	0.000243	CcSEcCtD
Pergolide—Vomiting—Losartan—type 2 diabetes mellitus	1.68e-05	0.000234	CcSEcCtD
Pergolide—Nausea—Irbesartan—type 2 diabetes mellitus	1.67e-05	0.000232	CcSEcCtD
Pergolide—Rash—Losartan—type 2 diabetes mellitus	1.67e-05	0.000232	CcSEcCtD
Pergolide—Dermatitis—Losartan—type 2 diabetes mellitus	1.66e-05	0.000232	CcSEcCtD
Pergolide—Headache—Losartan—type 2 diabetes mellitus	1.65e-05	0.000231	CcSEcCtD
Pergolide—Asthenia—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000226	CcSEcCtD
Pergolide—Pruritus—Ramipril—type 2 diabetes mellitus	1.6e-05	0.000223	CcSEcCtD
Pergolide—Nausea—Losartan—type 2 diabetes mellitus	1.57e-05	0.000219	CcSEcCtD
Pergolide—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.55e-05	0.000216	CcSEcCtD
Pergolide—Dizziness—Ramipril—type 2 diabetes mellitus	1.5e-05	0.000209	CcSEcCtD
Pergolide—Vomiting—Ramipril—type 2 diabetes mellitus	1.44e-05	0.000201	CcSEcCtD
Pergolide—Rash—Ramipril—type 2 diabetes mellitus	1.43e-05	0.000199	CcSEcCtD
Pergolide—Dermatitis—Ramipril—type 2 diabetes mellitus	1.43e-05	0.000199	CcSEcCtD
Pergolide—Headache—Ramipril—type 2 diabetes mellitus	1.42e-05	0.000198	CcSEcCtD
Pergolide—Nausea—Ramipril—type 2 diabetes mellitus	1.35e-05	0.000187	CcSEcCtD
Pergolide—DRD4—Signaling Pathways—SRC—type 2 diabetes mellitus	8.86e-07	1.91e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	8.85e-07	1.9e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.83e-07	1.9e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.83e-07	1.9e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.83e-07	1.9e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.83e-07	1.9e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	8.82e-07	1.9e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.8e-07	1.89e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.79e-07	1.89e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.77e-07	1.89e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	8.73e-07	1.88e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	8.71e-07	1.87e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	8.71e-07	1.87e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	8.69e-07	1.87e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	8.69e-07	1.87e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	8.69e-07	1.87e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	8.68e-07	1.87e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.68e-07	1.87e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.65e-07	1.86e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.65e-07	1.86e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.64e-07	1.86e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.63e-07	1.86e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.61e-07	1.85e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	8.59e-07	1.85e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.56e-07	1.84e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.54e-07	1.84e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.54e-07	1.84e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	8.53e-07	1.83e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.53e-07	1.83e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	8.48e-07	1.82e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	8.46e-07	1.82e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	8.45e-07	1.82e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.44e-07	1.82e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	8.44e-07	1.82e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.44e-07	1.82e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.39e-07	1.8e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.39e-07	1.8e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	8.31e-07	1.79e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	8.31e-07	1.79e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.28e-07	1.78e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.28e-07	1.78e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	8.27e-07	1.78e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.24e-07	1.77e-05	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.23e-07	1.77e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.22e-07	1.77e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.21e-07	1.77e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.18e-07	1.76e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.15e-07	1.75e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	8.14e-07	1.75e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.14e-07	1.75e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.14e-07	1.75e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.1e-07	1.74e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IL6—type 2 diabetes mellitus	8.09e-07	1.74e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.06e-07	1.73e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.05e-07	1.73e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.04e-07	1.73e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.03e-07	1.73e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.01e-07	1.72e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.01e-07	1.72e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8e-07	1.72e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	7.99e-07	1.72e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.98e-07	1.72e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	7.97e-07	1.71e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	7.95e-07	1.71e-05	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.94e-07	1.71e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.92e-07	1.7e-05	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.9e-07	1.7e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.89e-07	1.7e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.87e-07	1.69e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	7.87e-07	1.69e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	7.87e-07	1.69e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	7.86e-07	1.69e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	7.86e-07	1.69e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.84e-07	1.69e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.84e-07	1.69e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.83e-07	1.68e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.82e-07	1.68e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.78e-07	1.67e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.77e-07	1.67e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.76e-07	1.67e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	7.74e-07	1.66e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.71e-07	1.66e-05	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.69e-07	1.65e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.66e-07	1.65e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.66e-07	1.65e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	7.66e-07	1.65e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.63e-07	1.64e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.62e-07	1.64e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.62e-07	1.64e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	7.61e-07	1.64e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	7.58e-07	1.63e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.57e-07	1.63e-05	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.57e-07	1.63e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.56e-07	1.63e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	7.54e-07	1.62e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	7.53e-07	1.62e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	7.53e-07	1.62e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.5e-07	1.61e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	7.49e-07	1.61e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.47e-07	1.61e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.46e-07	1.6e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.45e-07	1.6e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.44e-07	1.6e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.41e-07	1.59e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.4e-07	1.59e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	7.38e-07	1.59e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.36e-07	1.58e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.32e-07	1.57e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.29e-07	1.57e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.29e-07	1.57e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.21e-07	1.55e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.2e-07	1.55e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.18e-07	1.54e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.13e-07	1.53e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.12e-07	1.53e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	7.1e-07	1.53e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.08e-07	1.52e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.03e-07	1.51e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.03e-07	1.51e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.01e-07	1.51e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.99e-07	1.5e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.98e-07	1.5e-05	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.98e-07	1.5e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.92e-07	1.49e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.91e-07	1.49e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.9e-07	1.48e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.9e-07	1.48e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.87e-07	1.48e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.87e-07	1.48e-05	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.86e-07	1.48e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	6.86e-07	1.48e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	6.86e-07	1.48e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	6.82e-07	1.47e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.8e-07	1.46e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.76e-07	1.45e-05	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.72e-07	1.45e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.68e-07	1.44e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.66e-07	1.43e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.65e-07	1.43e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	6.64e-07	1.43e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.62e-07	1.42e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	6.6e-07	1.42e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	6.53e-07	1.4e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.53e-07	1.4e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	6.49e-07	1.4e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.49e-07	1.4e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	6.48e-07	1.39e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	6.46e-07	1.39e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.46e-07	1.39e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.46e-07	1.39e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.43e-07	1.38e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	6.38e-07	1.37e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.36e-07	1.37e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.36e-07	1.37e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.35e-07	1.37e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.33e-07	1.36e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.29e-07	1.35e-05	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.24e-07	1.34e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.23e-07	1.34e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.23e-07	1.34e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.23e-07	1.34e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	6.19e-07	1.33e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	6.19e-07	1.33e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.19e-07	1.33e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.15e-07	1.32e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.13e-07	1.32e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.1e-07	1.31e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.1e-07	1.31e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	6.06e-07	1.3e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	6.02e-07	1.3e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	6.02e-07	1.3e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.01e-07	1.29e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.98e-07	1.29e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	5.97e-07	1.28e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.94e-07	1.28e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.93e-07	1.28e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.92e-07	1.27e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.91e-07	1.27e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.86e-07	1.26e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.85e-07	1.26e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.84e-07	1.26e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.82e-07	1.25e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.8e-07	1.25e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.79e-07	1.24e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.78e-07	1.24e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.77e-07	1.24e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.77e-07	1.24e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.72e-07	1.23e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.71e-07	1.23e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.7e-07	1.23e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.68e-07	1.22e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	5.68e-07	1.22e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.67e-07	1.22e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.65e-07	1.22e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.62e-07	1.21e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.59e-07	1.2e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.55e-07	1.19e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.51e-07	1.18e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.39e-07	1.16e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.38e-07	1.16e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.37e-07	1.16e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	5.32e-07	1.14e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	5.3e-07	1.14e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	5.3e-07	1.14e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.3e-07	1.14e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.28e-07	1.14e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.26e-07	1.13e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.25e-07	1.13e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	5.22e-07	1.12e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	5.19e-07	1.12e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.19e-07	1.12e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.19e-07	1.12e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.08e-07	1.09e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	5.06e-07	1.09e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.97e-07	1.07e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.96e-07	1.07e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.96e-07	1.07e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	4.93e-07	1.06e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.9e-07	1.05e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.89e-07	1.05e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.89e-07	1.05e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.82e-07	1.04e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	4.79e-07	1.03e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.72e-07	1.02e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.62e-07	9.94e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	4.6e-07	9.89e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	4.47e-07	9.61e-06	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.41e-07	9.5e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	4.4e-07	9.46e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	4.32e-07	9.28e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.26e-07	9.17e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.24e-07	9.12e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	4.23e-07	9.11e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.12e-07	8.87e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.06e-07	8.73e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.06e-07	8.72e-06	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	4.01e-07	8.62e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.99e-07	8.58e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.91e-07	8.41e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.88e-07	8.35e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.74e-07	8.05e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.71e-07	7.99e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.71e-07	7.99e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.68e-07	7.92e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.63e-07	7.81e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.61e-07	7.75e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.4e-07	7.3e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.35e-07	7.2e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.61e-07	5.61e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.71e-07	3.67e-06	CbGpPWpGaD
